(Downloading may take up to 30 seconds.
If the slide opens in your browser, select File -> Save As to save it.)
Click on image to view larger version.

Fig. 2. Influence of VEGF on retinal cell proliferation. (A) Effects
of VEGF concentrations on BrdU incorporation in vitro. E5-E7 explants were
labeled with BrdU for the last 6 hours (n=4 or 5). (B-D)
Western blots show sFLK1 (B), VEGF (C) or FLK1-DN (D) expression. Culture
media of transfected HEK cells (B,C) or infected DF-1 cell extracts (D) were
probed with antibodies against AP (B), VEGF (C) or FLAG tag (D). Controls used
were CMV-AP (B,C) or RCAS-AP virus (D). Arrowheads indicate bands with
expected molecular weights. (E-G) Immunostaining show effects of AP
(E), sFLK1 (F) or VEGF (G) in E5-E7 explants on BrdU labeling for the last 3
hours. Scale bars: 50 µm. (H) Effects of sFLK1- and VEGF-producing
cells on BrdU incorporation (3 hours) at E5 in vivo. Black and white bars
represent implanted and the contralateral non-implanted eyes, respectively
(n=5 or 6; *P<0.03). (I) Effect of FLK1-DN
expression on BrdU incorporation in vivo. Retinas infected at HH stage 10 with
RCAS-AP (control) or RCAS-FLK1-DN virus were harvested at E5 and labeled with
BrdU for 3 hours (n=5; *P<0.04).